Document Detail

Colon salvage therapy for acute severe colitis: cyclosporine or infliximab?
MedLine Citation:
PMID:  21423006     Owner:  NLM     Status:  Publisher    
PURPOSE OF REVIEW: Steroid-refractory acute severe colitis (ASC) poses a significant clinical challenge to both physicians and surgeons alike. This review highlights advances in management of these patients and the role of cyclosporine compared to infliximab. RECENT FINDINGS: ASC affects 25% of patients with ulcerative colitis and is associated with measurable morbidity and mortality. Simple clinical and laboratory measures predict steroid refractoriness (such as stool frequency 3-8/day and C-reactive protein > 45 mg/l on day 3) and salvage therapy is appropriate at this stage. Preliminary data from randomized controlled trials suggest that early (7 and 98 day) response to cyclosporine and infliximab are comparable. Serum trough infliximab concentrations may correlate with outcome. Sequential therapy cannot usually be recommended due to limited response (70% colectomy at 3 years) and high rate of serious adverse events. SUMMARY: Optimal salvage therapy will depend on detailed results of randomized controlled trials. Meanwhile, patients with ASC should receive either cyclosporine or infliximab before surgery as long as there is specialist expertise that allows early decision-making.
Daniel C Burger; Simon Travis
Related Documents :
17159386 - Objective assessment of nasal obstruction in snoring and obstructive sleep apnea patien...
21238966 - Urodynamic and clinical effects of transvaginal mesh repair for severe cystocele with a...
21242866 - The risk assessment of a fall in patients with lumbar spinal stenosis.
19172626 - Microdebrider-assisted versus radiofrequency-assisted inferior turbinoplasty.
21491136 - Preliminary outcomes 1 year after laparoscopic sleeve gastrectomy based on bariatric an...
6372066 - Comparative study of cimetidine and trimipramine in the short-term treatment of duodena...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-17
Journal Detail:
Title:  Current opinion in gastroenterology     Volume:  -     ISSN:  1531-7056     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8506887     Medline TA:  Curr Opin Gastroenterol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Update of chronic hepatitis B.
Next Document:  Hepatobiliary pathology.